title: Biomarkers and surrogate end points in clinical trials of tuberculosis treatment.
authors.forename: Geraint Rhys
authors.initials: GR
authors.lastname: Davies
authors.forename: Patrick P J
authors.initials: PP
authors.lastname: Phillips
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Nunn
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D015415:Biomarkers; D002986:Clinical Trials as Topic; D006801:Humans; D012008:Recurrence; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000995:Antitubercular Agents; D015415:Biomarkers